Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma

NCT07245368 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Asthma

Interventions

DRUG: PRA-216
DRUG: Placebo

Sponsor

Prana Therapies Inc